Company intelligence / Profile preview

Zhongjing Weishi

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Zhejiang Weishi Biotechnology specializes in the production of oil-soluble vitamins such as vitamin A palmitate, D3, E, K1—primarily for use in food fortification and dietary supplements. The company has developed double-microencapsulation technology for improved stability of its products. It holds GMP, HACCP, ISO22000/9001 certifications and supplies both domestic Chinese and international markets. No clinical trial results or pharmaceutical drug candidates have been reported.

Therapeutic areas: Metabolic DisordersOther
Modalities: Small molecule (vitamins and nutritional additives)Protein (coenzyme Q10 and similar compounds)Plant extract (nutritional supplements)Amino acid (nutritional supplements)Mineral (nutritional supplements)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Zhongjing Weishi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongjing Weishi.

Explore the full profile